EUROLAB
iso-14698-1-biocontamination-control-in-cleanrooms-and-controlled-environments
Sterility and Microbial Limit Testing 21 CFR Part 211.113 Control of Microbiological Contamination21 CFR Part 211.165 Testing and Release for Distribution21 CFR Part 211.167 Special Testing RequirementsAOAC 2003.01 Testing for Escherichia coli and ColiformsAOAC 2003.07 Microbial Enumeration for Nutritional SupplementsAOAC 966.23 Microbial Limits in CosmeticsEN 556-1 Requirements for Medical Devices Labeled ‘Sterile’EN 556-2 Requirements for Sterile Barrier SystemsEN 868-1 Packaging Materials for Terminally Sterilized Medical DevicesEN 868-2 Sterilization WrapsEN 868-3 Paper for Use in SterilizationEN 868-4 Paper Bags for Steam SterilizationEN 868-5 Heat Sealable PouchesEN 868-6 Paper for Low Temperature SterilizationEN 868-7 Nonwoven WrapsEN 868-8 Reusable Textiles for Sterile Barrier SystemsEN ISO 11607-1 Packaging for Terminally Sterilized Medical Devices – RequirementsEN ISO 11607-2 Packaging Validation RequirementsEP 2.6.1 Sterility Testing of Finished Dosage FormsEP 2.6.12 Microbiological Examination of Non-Sterile Products: Microbial Enumeration TestsEP 2.6.13 Microbiological Examination of Non-Sterile Products: Test for Specified MicroorganismsFDA BAM Chapter 10 Listeria monocytogenes DetectionFDA BAM Chapter 14 Bacillus cereus TestingFDA BAM Chapter 18 Microbial Limits for CosmeticsFDA BAM Chapter 3 Aerobic Plate Count for Food and SupplementsFDA BAM Chapter 4 Enumeration of Yeast and MoldFDA BAM Chapter 5 Coliforms and E. coli DetectionFDA BAM Chapter 7 Staphylococcus aureus DetectionFDA BAM Chapter 8 Salmonella DetectionICH Q10 Pharmaceutical Quality SystemICH Q6A Specifications for New Drug SubstancesICH Q6B Specifications for Biotechnological ProductsICH Q7 GMP for Active Pharmaceutical IngredientsICH Q9 Quality Risk ManagementISO 11135 Validation of Sterilization by Ethylene OxideISO 11137-1 Sterilization of Healthcare Products – RadiationISO 11137-2 Establishing the Sterilization DoseISO 11137-3 Guidance on Dosimetric Aspects for Radiation SterilizationISO 11138-1 Biological Indicators – General RequirementsISO 11138-2 Biological Indicators for Ethylene Oxide Sterilization ProcessesISO 11138-3 Biological Indicators for Steam Sterilization ProcessesISO 11138-4 Biological Indicators for Dry Heat Sterilization ProcessesISO 11138-5 Biological Indicators for Low-Temperature Steam and FormaldehydeISO 11737-1 Bioburden Determination on Medical DevicesISO 11737-2 Tests of Sterility Assurance for Medical DevicesISO 13408-1 Aseptic Processing of Healthcare ProductsISO 13408-2 Sterilizing FiltrationISO 13408-3 Lyophilization for Aseptic ProcessingISO 13408-4 Clean-in-Place for Aseptic ProcessingISO 13408-5 Sterilization-in-PlaceISO 13408-6 Isolator Systems for Aseptic ProcessingISO 13408-7 Aseptic ConnectionsISO 14160 Sterilization of Medical Devices Using Liquid Chemical SterilantsISO 14644-1 Cleanroom Classification by Particle CountISO 14644-10 Classification of Surface Chemical CleanlinessISO 14644-2 Cleanroom Monitoring to Provide Evidence of CleanlinessISO 14644-3 Test Methods for CleanroomsISO 14644-4 Design, Construction and Start-Up of CleanroomsISO 14644-5 Operations in CleanroomsISO 14644-6 VocabularyISO 14644-7 Separative Devices (Clean Air Hoods, Gloveboxes, etc.)ISO 14644-8 Airborne Molecular ContaminationISO 14644-9 Classification of Surface Particle CleanlinessISO 14698-2 Evaluation Methods for Biocontamination ControlISO 14937 General Requirements for Sterilization ProcessesISO 15883-1 Washer-Disinfectors for Medical DevicesISO 15883-2 Washer-Disinfectors for Surgical InstrumentsISO 15883-3 Washer-Disinfectors for Human Waste ContainersISO 15883-4 Washer-Disinfectors for Thermolabile EndoscopesISO 15883-5 Test Soils and Methods for Washer-DisinfectorsISO 15883-6 Washer-Disinfectors for Baby Bottles and UtensilsISO 17665-1 Moist Heat Sterilization of Healthcare ProductsISO 17665-2 Guidance on Moist Heat Sterilization ValidationISO 18362 Manufacture of Sterile Medicinal ProductsJP 4.05 Sterility Testing for Injectable ProductsJP 4.06 Microbial Limit Tests for Pharmaceutical ProductsPDA TR 1 Sterility Testing GuidelinePDA TR 27 Pharmaceutical Package IntegrityPDA TR 28 Process Simulation TestingPDA TR 36 Isolator Systems for Sterility AssurancePDA TR 69 Bioburden and Cleanroom Microbial ControlPDA TR 70 Sterilization of Drug Products by Moist HeatPh. Eur. 2.6.30 Bacterial Endotoxins – LAL TestPh. Eur. 5.1.10 Guidelines for Viral Safety of Biotechnological ProductsPh. Eur. 5.1.2 Biological Indicators for Sterilization ProcessesPh. Eur. 5.1.4 Cleanroom and Isolator Environmental MonitoringPh. Eur. 5.1.6 Container Closure Integrity for Sterile ProductsPh. Eur. 5.1.8 Microbiological Quality of Herbal PreparationsTGA TG-GMP Sterility Requirements for Medicinal ProductsUSP <1211> Sterilization and Sterility AssuranceUSP <1222> Terminally Sterilized Drug ProductsUSP <1229> Sterilization of Compendial ArticlesUSP <1231> Water for Pharmaceutical PurposesUSP <2021> Microbiological Testing of Nutritional and Dietary SupplementsUSP <2022> Microbiological Testing of Nonsterile Personal Care ProductsUSP <55> Biological Indicators – Resistance Performance TestsUSP <61.1> Microbial Limit Testing for CosmeticsUSP <61> Microbial Enumeration Test for Non-Sterile ProductsUSP <62> Test for Specified Microorganisms in Pharmaceutical ProductsUSP <71> Sterility Test for Parenteral Drug Products

ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments: Eurolabs Laboratory Testing Service

The ISO 14698-1 standard, also known as Biocontamination Control in Cleanrooms and Controlled Environments, is an international standard that outlines the requirements for controlling biocontamination in cleanrooms and controlled environments. This standard applies to various industries, including pharmaceuticals, biotechnology, medical devices, and aerospace.

International Standards

  • ISO 14698-1:2019 - Biocontamination control in cleanrooms and associated controlled environments - Part 1: General principles and methods
  • ASTM E2275-10(2020) - Standard Guide for Controlling Biocontamination in Cleanrooms
  • EN ISO 14698-1:2019 - Biocontamination control in cleanrooms and associated controlled environments - Part 1: General principles and methods
  • Standard Development Organizations

    The International Organization for Standardization (ISO), the American Society for Testing and Materials (ASTM), and the European Committee for Standardization (CEN) are among the organizations responsible for developing and maintaining standards related to biocontamination control in cleanrooms.

    Legal and Regulatory Framework

    Regulatory agencies, such as the US FDA and the EUs EMA, require compliance with ISO 14698-1 for controlled environments used in pharmaceutical, biotechnology, and medical device manufacturing. Failure to comply can result in significant consequences, including product recalls, fines, and reputational damage.

    International and National Standards

    The following national and international standards apply to biocontamination control in cleanrooms:

  • US: ASTM E2275-10(2020), FDA 21 CFR Part 211
  • EU: EN ISO 14698-1:2019, EU GMP Chapter 7
  • Japan: JIS Z 9001
  • Standard Compliance Requirements

    Industries requiring compliance with ISO 14698-1 include:

  • Pharmaceuticals (GxP)
  • Biotechnology (GxP)
  • Medical Devices (ISO 13485)
  • Aerospace (AS9100)
  • Business and Technical Reasons for Conducting ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments Testing

    The primary reasons for conducting this testing are:

    1. Ensuring product safety and quality

    2. Maintaining regulatory compliance

    3. Demonstrating a commitment to quality management and risk reduction

    4. Enhancing customer confidence and trust

    Consequences of Not Performing ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments Testing

    The consequences of not performing this testing include:

    1. Product recalls

    2. Financial losses due to regulatory non-compliance

    3. Reputational damage

    4. Loss of customer confidence and trust

    Risk Factors and Safety Implications

    The risk factors associated with biocontamination control in cleanrooms include:

  • Contamination of products and equipment
  • Infection transmission among personnel
  • Product failure and recalls
  • Quality Assurance and Quality Control Aspects

    To ensure the accuracy and reliability of test results, Eurolab implements a quality management system (QMS) that includes:

    1. Standard operating procedures (SOPs)

    2. Calibration and validation of equipment

    3. Training and certification of personnel

    4. Regular audits and assessments

    Why ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments Testing is Needed and Required

    This testing is necessary to ensure the quality and safety of products manufactured in controlled environments. Failure to perform this testing can result in significant consequences, including product recalls, fines, and reputational damage.

    Business and Technical Reasons for Conducting ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments Testing

    The primary reasons for conducting this testing are:

    1. Ensuring product safety and quality

    2. Maintaining regulatory compliance

    3. Demonstrating a commitment to quality management and risk reduction

    4. Enhancing customer confidence and trust

    Consequences of Not Performing ISO 14698-1 Biocontamination Control in Cleanrooms and Controlled Environments Testing

    The consequences of not performing this testing include:

    1. Product recalls

    2. Financial losses due to regulatory non-compliance

    3. Reputational damage

    4. Loss of customer confidence and trust

    Risk Factors and Safety Implications

    The risk factors associated with biocontamination control in cleanrooms include:

  • Contamination of products and equipment
  • Infection transmission among personnel
  • Product failure and recalls
  • Quality Assurance and Quality Control Aspects

    To ensure the accuracy and reliability of test results, Eurolab implements a quality management system (QMS) that includes:

    1. Standard operating procedures (SOPs)

    2. Calibration and validation of equipment

    3. Training and certification of personnel

    4. Regular audits and assessments

    Test Methodologies and Instruments

    Eurolab employs various testing methodologies and instruments to detect biocontamination, including:

    1. Air sampling using sterile filters

    2. Surface sampling using swabs or contact plates

    3. Liquid sampling using sterile vials

    4. PCR (Polymerase Chain Reaction) analysis for microbial identification

    Test Report and Certification

    Eurolab provides a comprehensive test report that includes:

    1. A summary of the testing methodology employed

    2. The results of the biocontamination control tests, including any detected contaminants

    3. Recommendations for corrective actions to reduce or eliminate contamination

    Standards and Regulations Compliance

    Eurolab ensures compliance with relevant national and international standards and regulations, including:

  • ISO 14698-1:2019 - Biocontamination control in cleanrooms and associated controlled environments - Part 1: General principles and methods
  • ASTM E2275-10(2020) - Standard Guide for Controlling Biocontamination in Cleanrooms
  • EN ISO 14698-1:2019 - Biocontamination control in cleanrooms and associated controlled environments - Part 1: General principles and methods
  • Test Report Format

    Eurolabs test report format includes:

    1. A cover page with the company logo, report title, and client information

    2. An executive summary of the testing methodology employed and the results obtained

    3. Detailed descriptions of the sampling methodologies used

    4. Tables and figures illustrating the test results

    5. Conclusions and recommendations for corrective actions

    Test Report Timeline

    Eurolab provides a comprehensive timeline for reporting test results, including:

    1. Initial report submission within 2-5 working days after testing completion

    2. Final report submission with any additional information or clarification within 10-14 working days after initial report submission

    This is just a starting point, and you can add more content to the guide as per your requirements. Please note that this is a comprehensive guide and might need to be broken down into smaller sections for easier reading and understanding.

    Also, please ensure that all the information provided is accurate and up-to-date, and that any references or citations are properly formatted according to your specific needs.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers